Pascal Coudert

615 total citations
54 papers, 505 citations indexed

About

Pascal Coudert is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Pascal Coudert has authored 54 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Organic Chemistry, 21 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Pascal Coudert's work include Synthesis and Characterization of Heterocyclic Compounds (15 papers), Phenothiazines and Benzothiazines Synthesis and Activities (13 papers) and Synthesis and biological activity (11 papers). Pascal Coudert is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (15 papers), Phenothiazines and Benzothiazines Synthesis and Activities (13 papers) and Synthesis and biological activity (11 papers). Pascal Coudert collaborates with scholars based in France, Russia and New Zealand. Pascal Coudert's co-authors include Catherine Rubat, J. COUQUELET, P Bastide, M. Madesclaire, Stéphane Moreau, Eric Débiton, Claire Lartigue, J. Bastide, Jean‐Claude Madelmont and Daniel Gardette and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Pascal Coudert

46 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Coudert France 13 359 151 55 37 23 54 505
L. D. Konyushkin Russia 14 547 1.5× 180 1.2× 67 1.2× 59 1.6× 25 1.1× 72 666
Luísa C. R. Carvalho Portugal 9 412 1.1× 158 1.0× 55 1.0× 21 0.6× 19 0.8× 17 526
Amanda L. Rousseau South Africa 14 706 2.0× 199 1.3× 46 0.8× 43 1.2× 32 1.4× 38 866
Stéphane Poigny France 13 249 0.7× 124 0.8× 56 1.0× 35 0.9× 13 0.6× 29 397
Pedro Brandão Portugal 13 316 0.9× 171 1.1× 63 1.1× 37 1.0× 50 2.2× 30 537
Achintya K. Sinhababu United States 16 293 0.8× 262 1.7× 50 0.9× 13 0.4× 46 2.0× 36 621
Frank J. Urban United States 13 304 0.8× 247 1.6× 29 0.5× 9 0.2× 17 0.7× 33 452
Fang‐Dao Wang China 9 143 0.4× 249 1.6× 56 1.0× 17 0.5× 37 1.6× 16 429
Byoung Mog Kwon South Korea 11 159 0.4× 182 1.2× 34 0.6× 24 0.6× 27 1.2× 20 467
Kinfe K. Redda United States 13 333 0.9× 120 0.8× 65 1.2× 35 0.9× 27 1.2× 57 481

Countries citing papers authored by Pascal Coudert

Since Specialization
Citations

This map shows the geographic impact of Pascal Coudert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Coudert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Coudert more than expected).

Fields of papers citing papers by Pascal Coudert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Coudert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Coudert. The network helps show where Pascal Coudert may publish in the future.

Co-authorship network of co-authors of Pascal Coudert

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Coudert. A scholar is included among the top collaborators of Pascal Coudert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Coudert. Pascal Coudert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coudert, Pascal, et al.. (2021). Les médicaments de la douleur. Actualités Pharmaceutiques. 60(603). 31–35. 1 indexed citations
2.
Coudert, Pascal. (2018). Les principales maladies du porc. Actualités Pharmaceutiques. 57(580). 50–55. 3 indexed citations
3.
Madesclaire, M., et al.. (2015). Synthesis and Antimicrobial Activity of New Ureas from (1S,2S)-2-Amino-1-(4-Nitrophenyl)-1,3-Propanediol. Pharmaceutical Chemistry Journal. 49(1). 10–12. 5 indexed citations
5.
Chezal, Jean‐Michel, et al.. (2011). Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs. European Journal of Medicinal Chemistry. 46(7). 2867–2879. 18 indexed citations
6.
Rubat, Catherine, et al.. (2005). New 3- and 4-hydroxyfuranones as anti-oxidants and anti-inflammatory agents. Bioorganic & Medicinal Chemistry. 13(14). 4552–4564. 52 indexed citations
7.
Coudert, Pascal, et al.. (2000). Antioxidant Properties of Novel Lipophilic Ascorbic Acid Analogues. Journal of Pharmacy and Pharmacology. 52(5). 523–530. 16 indexed citations
8.
Moreau, Stéphane, Pascal Coudert, Catherine Rubat, et al.. (1998). Synthesis and anticonvulsant properties of triazolo- and imidazopyridazinyl carboxamides and carboxylic acids. Bioorganic & Medicinal Chemistry. 6(7). 983–991. 29 indexed citations
9.
Coudert, Pascal, et al.. (1998). Synthesis of new pyrrolo[1,2-d][1,2,4]triazines and thiazolo[3,4-d][1,2,4]triazines as immunostimulating agents. Bioorganic & Medicinal Chemistry. 6(3). 349–354. 7 indexed citations
10.
Rubat, Catherine, et al.. (1997). Synthesis and analgesic effects of 3-substituted 4,6-diarylpyridazine derivatives of the arylpiperazine class. Bioorganic & Medicinal Chemistry. 5(4). 655–659. 39 indexed citations
12.
Moreau, Stéphane, Pascal Coudert, Catherine Rubat, et al.. (1994). Synthesis and Anticonvulsant Properties of New Benzylpyridazine Derivatives. Journal of Medicinal Chemistry. 37(14). 2153–2160. 27 indexed citations
13.
Coudert, Pascal, et al.. (1994). Synthesis of pyridazine acetic acid derivatives possessing aldose reductase inhibitory activity and antioxidant properties. European Journal of Medicinal Chemistry. 29(6). 471–477. 22 indexed citations
14.
Mavel, Sylvie, et al.. (1993). Synthesis of new 5-substituted pyrazolo[1,5-d][1,2,4]-triazine derivatives and their analgesic, anti-inflammatory and antipyretic properties.. PubMed. 43(4). 464–8. 6 indexed citations
15.
Coudert, Pascal, et al.. (1992). [Synthesis and evaluation of the aldose reductase inhibitory activity of new diaryl pyridazine-3-ones].. PubMed. 46(6). 375–80. 10 indexed citations
16.
Coudert, Pascal, et al.. (1991). [Synthesis and evaluation of central nervous system activity of new triaza-spirodecanediones].. PubMed. 66(5-6). 155–9. 4 indexed citations
17.
Coudert, Pascal, et al.. (1990). Synthesis of 6-[(4-imidazol-1-yl)-phenyl]-4-phenyl 4,5-dihydro-2H-pyridazin-3-one: a potential blood platelet aggregation inhibitor.. PubMed. 45(3). 191–5. 2 indexed citations
18.
Rubat, Catherine, et al.. (1990). Anticonvulsant activity of 3-oxo-5-substituted benzylidene-6-methyl-(4H)-2-pyridazinylacetamides and 2-pyridazinylacetylhydrazides.. Chemical and Pharmaceutical Bulletin. 38(11). 3009–3013. 33 indexed citations
19.
Coudert, Pascal, et al.. (1988). [Synthesis and anti-allergic properties of N-arylnitrones with furo-pyran structure].. PubMed. 46(2). 91–6. 31 indexed citations
20.
Coudert, Pascal, et al.. (1986). Synthesis of new spirobenzazolines including a furo[3,4‐b]pyran ring system. Journal of Heterocyclic Chemistry. 23(5). 1527–1529. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026